Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

P53 Mutations In Human Cancers.

M. Hollstein, D. Sidransky, B. Vogelstein, C. Harris
Published 1991 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Mutations in the evolutionarily conserved codons of the p53 tumor suppressor gene are common in diverse types of human cancer. The p53 mutational spectrum differs among cancers of the colon, lung, esophagus, breast, liver, brain, reticuloendothelial tissues, and hemopoietic tissues. Analysis of these mutations can provide clues to the etiology of these diverse tumors and to the function of specific regions of p53. Transitions predominate in colon, brain, and lymphoid malignancies, whereas G:C to T:A transversions are the most frequent substitutions observed in cancers of the lung and liver. Mutations at A:T base pairs are seen more frequently in esophageal carcinomas than in other solid tumors. Most transitions in colorectal carcinomas, brain tumors, leukemias, and lymphomas are at CpG dinucleotide mutational hot spots. G to T transversions in lung, breast, and esophageal carcinomas are dispersed among numerous codons. In liver tumors in persons from geographic areas in which both aflatoxin B1 and hepatitis B virus are cancer risk factors, most mutations are at one nucleotide pair of codon 249. These differences may reflect the etiological contributions of both exogenous and endogenous factors to human carcinogenesis.
This paper references
10.1093/CARCIN/10.9.1563
Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair.
C. Harris (1989)
10.1126/SCIENCE.2783787
Detecting mutations in human genes.
J. Marx (1989)
10.1038/350429A0
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
B. Bressac (1991)
10.1126/SCIENCE.2649981
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
S. Baker (1989)
10.1073/PNAS.87.24.9958
Frequent mutation of the p53 gene in human esophageal cancer.
M. Hollstein (1990)
10.1146/ANNUREV.GE.20.120186.001221
Mutagenesis by apurinic/apyrimidinic sites.
L. Loeb (1986)
10.1016/0092-8674(87)90151-6
Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene
I. Mellon (1987)
10.1093/CARCIN/11.12.2271
Aflatoxin-albumin adducts in human sera from different regions of the world.
C. Wild (1990)
10.1073/PNAS.80.1.6
Sequence specificity in aflatoxin B1--DNA interactions.
K. Muench (1983)
10.1016/0165-1218(90)90028-Z
The effect of the pyrrolizidine alkaloid integerrimine on the chromosomes of mouse bone marrow cells.
M. C. Gimmler-Luz (1990)
10.1016/0165-1110(90)90020-C
Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis.
W. Lutz (1990)
10.1128/JVI.63.2.739-746.1989
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
P. Hinds (1989)
Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
Joseph W. Romano (1989)
10.1073/PNAS.87.3.1104
Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
G. Mcmahon (1990)
10.1126/SCIENCE.2554494
p53: a frequent target for genetic abnormalities in lung cancer.
T. Takahashi (1989)
10.1073/PNAS.85.10.3499
Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level.
P. D. de Jong (1988)
10.1128/MCB.10.11.5772
p53 functions as a cell cycle control protein in osteosarcomas.
L. Diller (1990)
10.1289/EHP.87769
Preferential DNA repair in expressed genes.
P. Hanawalt (1987)
10.1126/SCIENCE.2157286
Association of human papillomavirus types 16 and 18 E6 proteins with p53.
B. Werness (1990)
10.1073/PNAS.86.22.8763
Wild-type p53 can inhibit oncogene-mediated focus formation.
D. Eliyahu (1989)
Increased cell division as a cause of human cancer.
S. Preston-Martin (1990)
10.1016/0165-1110(90)90019-8
Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues.
M. Ehrlich (1990)
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
Jane Prosser (1990)
10.1073/PNAS.84.21.7716
Rearrangement of the p53 gene in human osteogenic sarcomas.
H. Masuda (1987)
Frequency and structure of p53 rearrangements in human osteosarcoma.
C. Miller (1990)
10.1016/0169-5002(91)90309-t
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
I. Chiba (1990)
10.1073/PNAS.87.15.5863
Mechanisms of p53 loss in human sarcomas.
L. Mulligan (1990)
10.1021/BI00482A011
Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome.
M. Wood (1990)
10.1073/PNAS.87.19.7555
p53 mutations in colorectal cancer.
N. Rodrigues (1990)
10.1038/320182A0
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
O. Pinhasi-Kimhi (1986)
10.1038/272633A0
Human pulmonary alveolar macrophages metabolise benzo(a)pyrene to proximate and ultimate mutagens
C. Harris (1978)
10.1038/348681A0
A deadly inheritance
B. Vogelstein (1990)
10.1007/BF01534647
Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenousaprt gene in CHO cells
M. Mazur (1988)
10.1128/MCB.10.10.5502
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
J. Cheng (1990)
10.1126/SCIENCE.1697983
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.
W. Rideout (1990)
10.1073/PNAS.85.8.2706
Oxidative damage to DNA: relation to species metabolic rate and life span.
R. Adelman (1988)
10.1073/PNAS.87.21.8680
Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene.
R. Chen (1990)
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
S. Baker (1990)
10.1016/0092-8674(79)90293-9
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
D. Linzer (1979)
10.1146/ANNUREV.GE.17.120183.001243
Mutational specificity in bacteria.
J. H. Miller (1983)
10.1126/SCIENCE.2144363
Presence of a potent transcription activating sequence in the p53 protein.
S. Fields (1990)
10.1073/PNAS.86.24.9697
Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.
M. Shigenaga (1989)
10.1073/PNAS.82.3.790
Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
D. Wolf (1985)
10.1073/PNAS.87.19.7772
Chemical carcinogenesis: too many rodent carcinogens.
B. Ames (1990)
10.1073/PNAS.86.9.3070
Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
M. You (1989)
10.1073/PNAS.87.5.1973
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
B. Bressac (1990)
10.1016/S0065-230X(08)60222-5
Oncogene activation in chemical carcinogenesis.
A. Balmain (1988)
10.1126/SCIENCE.2144057
Suppression of human colorectal carcinoma cell growth by wild-type p53.
S. Baker (1990)
10.1002/EM.2850150208
Mutational specificity of alkylating agents and the influence of DNA repair
M. J. Horsfall (1990)
10.1038/278261A0
T antigen is bound to a host protein in SY40-transformed cells
D. Lane (1979)
Heterogeneous DNA damage and repair in the mammalian genome.
V. Bohr (1987)
10.1073/PNAS.80.9.2695
Base substitution mutations induced by metabolically activated aflatoxin B1.
P. Foster (1983)
10.1038/338389A0
The search for the causes of breast and colon cancer
W. Willett (1989)
10.1038/348747A0
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
S. Srivastava (1990)
10.1126/science.2047879
Identification of p53 as a sequence-specific DNA-binding protein
S. Kern (1991)
10.1016/0092-8674(82)90356-7
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
P. Sarnow (1982)
10.1126/SCIENCE.1978757
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D. Malkin (1990)
10.1146/ANNUREV.PA.30.040190.002101
Mutational spectrometry in animal toxicity testing.
W. Thilly (1990)
10.1016/0140-6736(90)90801-B
Increased expression of mutant forms of p53 oncogene in primary lung cancer
R. Iggo (1990)
10.1289/EHP.89819
Markers of exposure to carcinogens.
G. Wogan (1989)
10.1073/PNAS.87.14.5435
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
A. Menon (1990)
10.1128/JVI.62.10.3903-3906.1988
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen.
J. Jenkins (1988)
10.1038/342705A0
Mutations in the p53 gene occur in diverse human tumour types
J. Nigro (1989)
10.1126/SCIENCE.6262918
5-Methylcytosine in eukaryotic DNA.
M. Ehrlich (1981)
10.1073/PNAS.86.17.6783
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
H. Ahuja (1989)
10.1002/MC.2940030405
Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of dna base damage
L. Breimer (1990)
10.1038/349431A0
Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG
S. Shibutani (1991)
10.1073/PNAS.87.15.5842
Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells.
K. Wiebauer (1990)
10.1016/0092-8674(89)90045-7
The p53 proto-oncogene can act as a suppressor of transformation
C. Finlay (1989)
10.1038/350427A0
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
I. C. Hsu (1991)
10.1073/PNAS.87.16.6166
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
W. Mercer (1990)



This paper is referenced by
10.1159/000487956
Multiple Signal Pathways Involved in Crocetin-Induced Apoptosis in KYSE-150 Cells
S. Li (2019)
Current Progress in Covalent Modification of Biomolecules by Compounds in Food or Oxidatively Generated Compounds Its Relevance to Biological Functions
Y. Kawai (2017)
Identification of a p53-dependent negative response element in the bcl-2 gene.
T. Miyashita (1994)
The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
L. Zhang (2015)
10.17554/j.issn.2224-3992.2015.04.497
P53 Inducible Gene-3: Potential Serum Marker for Hepatocellular Carcinoma Beyond Milan Criteria
M. Bhat (2015)
10.18632/ONCOTARGET.1457
Targeting nucleocytoplasmic transport in cancer therapy
R. Hill (2014)
10.1007/978-81-322-0843-3_26
Breast Cancer Gene Therapy
G. Büyükköroğlu (2014)
10.1016/j.biomaterials.2013.10.073
p53 mediated apoptosis by reduction sensitive shielding ternary complexes based on disulfide linked PEI ternary complexes.
Yiyan He (2014)
10.1016/j.bbrc.2012.06.004
Depression of p53-independent Akt survival signals in human oral cancer cells bearing mutated p53 gene after exposure to high-LET radiation.
Y. Nakagawa (2012)
10.1074/jbc.M111.289108
Centrosomal Protein 55 (Cep55) Stability Is Negatively Regulated by p53 Protein through Polo-like Kinase 1 (Plk1)*
Y. Chang (2011)
10.1155/2011/476498
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
T. Hayashi (2011)
10.1007/978-3-642-39159-0_20
Inferring the Association Network from p53 Sequence Alignment Using Granular Evaluations
D. Chiu (2013)
10.1073/pnas.1019312108
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
L. Jin (2011)
10.3389/fgene.2013.00018
MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNA
Enni Markkanen (2013)
10.3892/ijo.2013.1829
Human hepatocyte carcinogenesis
H. Shiraha (2013)
10.1038/onc.2012.199
PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis
I. Rybanská (2013)
10.1007/s00408-013-9461-9
The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects
Qian Qiao (2013)
10.1021/tx200272v
Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.
Z. Abedin (2012)
10.1007/978-3-642-28397-0_12
Malignant Transformation of Melanocytic Nevi
Alexander Marzuka-Alcalá (2012)
10.1016/J.JOMS.2006.03.035
Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
M. Fukuda (2006)
10.1163/9789004391192
Animal Experimentation: Working Towards a Paradigm Change
K. Herrmann (2019)
10.1016/j.micinf.2017.06.001
Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
F. Faraji (2017)
10.1101/gad.304071.117
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
C. Katz (2018)
10.1097/MD.0000000000006424
Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract
X. Wang (2017)
10.3892/BR.2016.729
Gene mutations in Cushing's disease.
Q. Xiong (2016)
10.1016/j.vetimm.2016.05.012
Identification of a novel feline large granular lymphoma cell line (S87) as non-MHC-restricted cytotoxic T-cell line and assessment of its genetic instability.
L. Rydzewski (2016)
Molecular and genetic mechanisms of lymphomagenesis.
R. Kušec (2002)
10.1093/carcin/bgy093
Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein
S. Punganuru (2018)
Alterations of tumour protein 53 (TP53) pathways in diffuse large B-cell lymphomas
Dalia Magdi Abdel-Azim (2009)
The mechanisms of cellular sensitivity to photodynamic therapy
Z. Tong (2002)
Understanding the role of Merkel cell polyomavirus oncoproteins in the cellular transformation of mammalian Merkel cells
L. M. Knight (2014)
10.1002/cpsc.102
Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells.
Constanze Uhlmann (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar